| Symbol | QUCY |
|---|---|
| Name | MAINZ BIOMED N.V. |
| Sector | HEALTH CARE |
| Region | Europe |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | ROBERT-KOCH-STRASSE 50,SIRIUS GUTENBERG PARK, MAINZ, 55129, Netherlands |
| Telephone | +49 61315542860 |
| Fax | — |
| — | |
| Website | https://www.mainzbiomed.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001874252 |
| Description | Mainz Biomed BV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. Its main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results. Additional info from NASDAQ: |
Quantum Cyber Signs Definitive Agreements to Acquire U.S.-Based Manufacturing Facility in Bridgeport, Connecticut
Read moreQuantum Cyber Announces Compliance With Trump Administrations National Quantum Initiative Executive Order Following Washington D.C. Delegation and Capitol Hill Engagements
Read moreQuantum Cyber Unveils Quantum Station: A Battlefield Operating System for Multi-Domain Autonomous Warfare
Read moreCorrection: Quantum Cyber Executes Exclusive Quantum Antenna License Agreement, Positoning the Quantum Technology Layer at the Core of Its Defense Platform
Read more